ZA200606687B - Oxydecahydronaphthalene modulators of HM74 - Google Patents

Oxydecahydronaphthalene modulators of HM74

Info

Publication number
ZA200606687B
ZA200606687B ZA200606687A ZA200606687A ZA200606687B ZA 200606687 B ZA200606687 B ZA 200606687B ZA 200606687 A ZA200606687 A ZA 200606687A ZA 200606687 A ZA200606687 A ZA 200606687A ZA 200606687 B ZA200606687 B ZA 200606687B
Authority
ZA
South Africa
Prior art keywords
oxydecahydronaphthalene
modulators
oxydecahydronaphthalene modulators
Prior art date
Application number
ZA200606687A
Other languages
English (en)
Inventor
Minnich Anne
Eishingdrelo Haifeng
Henke Stephan
Kuntzweiler Theresa
Angelastro Michael
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of ZA200606687B publication Critical patent/ZA200606687B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
ZA200606687A 2004-02-20 2006-08-11 Oxydecahydronaphthalene modulators of HM74 ZA200606687B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20

Publications (1)

Publication Number Publication Date
ZA200606687B true ZA200606687B (en) 2008-02-27

Family

ID=34910747

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606687A ZA200606687B (en) 2004-02-20 2006-08-11 Oxydecahydronaphthalene modulators of HM74

Country Status (21)

Country Link
US (2) US7264937B2 (fr)
EP (1) EP1718293A1 (fr)
JP (1) JP2007526917A (fr)
KR (1) KR101145693B1 (fr)
CN (1) CN1929833A (fr)
AR (1) AR047708A1 (fr)
AU (1) AU2005216878B2 (fr)
BR (1) BRPI0507916A (fr)
CA (1) CA2556757C (fr)
CR (1) CR8537A (fr)
EC (1) ECSP066776A (fr)
IL (1) IL177106A (fr)
MA (1) MA28368A1 (fr)
ME (2) MEP17008A (fr)
NO (1) NO20064214L (fr)
RS (1) RS20060472A (fr)
RU (1) RU2006133539A (fr)
TN (1) TNSN06235A1 (fr)
TW (1) TWI354552B (fr)
WO (1) WO2005082352A1 (fr)
ZA (1) ZA200606687B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603585A2 (fr) * 2003-03-14 2005-12-14 Bristol-Myers Squibb Company Polynucleotide codant un nouveau variant de recepteur de hm74, hgprbmy74 couple a une proteine g humaine
NZ555320A (en) 2004-12-03 2010-11-26 Schering Corp Substituted piperazines as CB1 antagonists
CA2637565A1 (fr) * 2006-01-18 2007-07-26 Schering Corporation Modulateurs de recepteurs de cannibinoides
US20100197564A1 (en) * 2007-04-19 2010-08-05 Schering Corporation Diaryl morpholines as cb1 modulators
EP2548874A3 (fr) * 2007-06-28 2013-05-15 Intervet International B.V. Pipérazines substituées utilisées en tant qu'antagonistes CB1
JP2010531874A (ja) * 2007-06-28 2010-09-30 インターベット インターナショナル ベー． フェー． Ｃｂ１アンタゴニストとしての置換ピペラジン

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1007563A4 (fr) * 1997-06-12 2003-04-16 Smithkline Beecham Corp Recepteur hm74a
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
IL177106A0 (en) 2006-12-10
TWI354552B (en) 2011-12-21
JP2007526917A (ja) 2007-09-20
TW200539864A (en) 2005-12-16
MEP17008A (en) 2010-06-10
IL177106A (en) 2012-03-29
RS20060472A (en) 2008-11-28
RU2006133539A (ru) 2008-03-27
ME00059B (me) 2010-06-10
TNSN06235A1 (en) 2007-12-03
AU2005216878A1 (en) 2005-09-09
ECSP066776A (es) 2006-11-16
BRPI0507916A (pt) 2007-07-10
CA2556757C (fr) 2011-05-03
US20080045586A1 (en) 2008-02-21
MA28368A1 (fr) 2006-12-01
CN1929833A (zh) 2007-03-14
CR8537A (es) 2007-03-05
US20050187263A1 (en) 2005-08-25
CA2556757A1 (fr) 2005-09-09
US7264937B2 (en) 2007-09-04
KR101145693B1 (ko) 2012-05-25
EP1718293A1 (fr) 2006-11-08
WO2005082352A1 (fr) 2005-09-09
AR047708A1 (es) 2006-02-08
KR20060127982A (ko) 2006-12-13
AU2005216878B2 (en) 2010-06-17
NO20064214L (no) 2006-09-18

Similar Documents

Publication Publication Date Title
GB0420719D0 (en) Novel allosteric modulators
GB0420722D0 (en) Novel allosteric modulators
IL178290A0 (en) Tetrahydro-indazole cannabinoid modulators
IL232540A (en) Factor-site change of viii
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
PT1778618E (pt) Síntese de trietilenotetraminas
IL178029A (en) Use of sulfonylureas
EP1928489A4 (fr) Analogues de la ghreline
PL1737304T3 (pl) Zagęszczona płynna formuła
EP1751115A4 (fr) Modulateurs de theramuteine
EP1827473A4 (fr) Modulateurs de toxicite de l'alpha-synucleine
PL1763520T3 (pl) Zastosowanie tripodstawionych benzopiranonów
EP1711484A4 (fr) Synthese de cyanoimino-benzoimidazoles
HK1081282A1 (en) Chronograph
IL172276A0 (en) Cross-reference to related application
ZA200606687B (en) Oxydecahydronaphthalene modulators of HM74
GB0403889D0 (en) Uses of er-beta modulators
EP1721158A4 (fr) Modulateurs d'angiogenese
EP1831204A4 (fr) Composes ambruticine vs
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
GB0510501D0 (en) Display of operational instructions
EP1827482A4 (fr) Nouvelles utilisations de l'egf
GB0427954D0 (en) Modulator
AU158223S (en) Wristwatch
GB0422748D0 (en) Novel allosteric modulators